6 news items
Gritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate Updates
GRTS
9 May 24
subject, comparative Phase 2b study contracted by the Biomedical Advanced Research and Development Authority [BARDA]2). This decision
Gritstone bio Announces Appointment of Stephen Webster to its Board of Directors
GRTS
29 Apr 24
trials; the timing of commencement of our future nonclinical studies, clinical trials and research and development programs; our ability to discover
Gritstone bio Announces Positive Preliminary Progression-free Survival and Long-term Circulating Tumor DNA (ctDNA) Data from Phase 2 Portion of Ongoing Phase 2/3 Study of its Personalized Cancer Vaccine, GRANITE, in Front-line Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)
GRTS
1 Apr 24
in the final data; the timing of commencement and results of our future nonclinical studies, clinical trials and research and development programs; our
Gritstone bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
GRTS
5 Mar 24
with Gilead under Gilead's HIV Cure Program to research and develop vaccine-based HIV immunotherapy treatment
Why Is Gritstone Bio Stock Trading Lower?
GRTS
1 Mar 24
by the Biomedical Advanced Research and Development Authority (BARDA) to conduct a Phase 2b comparative study evaluating its self-amplifying mRNA (samRNA
5q0j29lxcns7
AKAN
CRDF
DELL
1 Mar 24
on its clinical research and development initiatives.
Akanda Corp
- Prev
- 1
- Next